Premium
276 SELECTIVE ACTIVATION OF CANNABINOID CB2 RECEPTORS SUPPRESSES CHEMOTHERAPEUTIC NEUROPATHY EVOKED BY PACLITAXEL AND VINCRISTINE ADMINISTRATION
Author(s) -
Hohmann A.G.,
Rahn E.J.,
Maxwell K.W.,
Zvonok Am.,
Makriyannis A.
Publication year - 2007
Publication title -
european journal of pain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.305
H-Index - 109
eISSN - 1532-2149
pISSN - 1090-3801
DOI - 10.1016/j.ejpain.2007.03.291
Subject(s) - paclitaxel , cannabinoid , vincristine , pharmacology , cannabinoid receptor type 2 , cannabinoid receptor , medicine , receptor , chemistry , agonist , chemotherapy , cyclophosphamide
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom